Frequencies for first 10,000 rows of rx3v2c2 variable in nhamcsopd2006 dataset : for rx3, level 2 of multum drug | category #2 | Freq. Percent Cum. ----------------------------------------+----------------------------------- Anti-infectives: antimalarial agents | 6 0.06 0.06 Anti-infectives: miscellaneous antibiot | 3 0.03 0.09 Anti-infectives: sulfanomides | 12 0.12 0.21 Antineoplastics: miscellaneous antineop | 1 0.01 0.22 Cardiovascular agents: diuretics | 1 0.01 0.23 Cardiovascular agents: vasodilators | 4 0.04 0.27 CNS: Analgesics | 1 0.01 0.28 CNS: Anticonvulsants | 71 0.71 0.99 CNS: Antiemetic/antivertigo agents: 5HT | 29 0.29 1.28 CNS: Anti-Parkinson agents | 2 0.02 1.30 Coagulation modifiers: antiplatelet age | 72 0.72 2.02 Gastrointestinal agents: H2 antagonists | 1 0.01 2.03 Hormones: adrenal cortical steroids | 11 0.11 2.14 Hormones: sex hormones | 5 0.05 2.19 Miscellaneous agents: antidotes | 1 0.01 2.20 Miscellaneous agents: local injectable | 23 0.23 2.43 Miscellaneous agents: genitourinary tra | 4 0.04 2.47 Nutritional products: minerals and elec | 8 0.08 2.55 Respiratory agents: antihistamines | 25 0.25 2.80 Respiratory agents: antitussives | 4 0.04 2.84 Respiratory agents: decongestants | 2 0.02 2.86 Respiratory agents: miscellaneous respi | 10 0.10 2.96 Respiratory agents: respiratory inhalan | 1 0.01 2.97 Topical agents: dermatological agents | 7 0.07 3.04 Topical agents: mouth and throat prod | 6 0.06 3.10 Topical agents: vaginal preprations | 6 0.06 3.16 Miscellaneous agents: antirheumatics | 9 0.09 3.25 Psychotherapeutic agents: antidepressan | 2 0.02 3.27 Psychotherapeutic agents: antipsychotic | 6 0.06 3.33 Metabolic agents: antihyperuricemic age | 7 0.07 3.40 Metabolic agents: glucose elevating age | 3 0.03 3.43 Cardiovascular agents: agents for pulmo | 4 0.04 3.47 Miscellaneous agents: smoking cessation | 19 0.19 3.66 Cardiovascular agents: aldosterone rece | 5 0.05 3.71 . | 9,629 96.29 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016